Jakub Chlebek

Jakub Chlebek

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
FFFilipe Fernandes
Filipe Fernandes
Maria Fatima BarrosoMaria Fatima Barroso
Maria Fatima Barroso
ASAngela De Simone
Angela De Simone
EEEliška Emriková
Eliška Emriková
MDMónica Dias-Teixeira
Mónica Dias-Teixeira
CGClara Grosso
Clara Grosso

1 September 2015 in Phytochemistry Letters
Verified
Journal Article
Closed access
IDIvo Doskocil
Ivo Doskocil
AHAnna Hošťálková
Anna Hošťálková
MŠMarcela Šafratová
Marcela Šafratová
NBNina Benešová
Nina Benešová
JHJaroslav Havlik
Jaroslav Havlik
Lucie CahlikovaLucie Cahlikova
Lucie Cahlikova

5 April 2019 in Molecules
Verified
Journal Article
Open access
PDF file
Jakub ChlebekJakub Chlebek
Jakub Chlebek
Jan KorabecnyJan Korabecny
Jan Korabecny
RDRafael Doležal
Rafael Doležal
ŠŠŠárka Štěpánková
Šárka Štěpánková
DPDaniel I. Pérez
Daniel I. Pérez
DJDaniel Jun
Daniel Jun
In recent studies, several alkaloids acting as cholinesterase inhibitors were isolated from Corydalis cava (Papaveraceae). Inhibitory activities of (+)-thalictricavine (1) and (+)-canadine (2) on human acetylcholinesterase (hAChE) and butyrylcholinesterase (hBChE) were evaluated with the Ellman’s spectrophotometric method. Molecular modeling was used to inspect the binding mode of compounds into the active site pocket of hAChE. The possible permeability of 1 and 2 through the blood–brain barrier (BBB) was predicted by the parallel artificial permeation assay (PAMPA) and logBB calculation. In vitro, 1 and 2 were found to be selective hAChE inhibitors with IC50 values of 0.38 ± 0.05 µM and 0.70 ± 0.07 µM, respectively, but against hBChE were considered inactive (IC50 values > 100 µM). Furthermore, both alkaloids demonstrated a competitive-type pattern of hAChE inhibition and bind, most probably, in the same AChE sub-site as its substrate. In silico docking experiments allowed us to confirm their binding poses into the active center of hAChE. Based on the PAMPA and logBB calculation, 2 is potentially centrally active, but for 1 BBB crossing is limited. In conclusion, 1 and 2 appear as potential lead compounds for the treatment of Alzheimer’s disease.

1 March 2016 in Fitoterapia
Verified
Journal Article
Open access
Jakub ChlebekJakub Chlebek
Jakub Chlebek
ASAngela De Simone
Angela De Simone
AHAnna Hošťálková
Anna Hošťálková
LOLubomír Opletal
Lubomír Opletal
CPConcepción Pérez
Concepción Pérez
VAVincenza Andrisano
Vincenza Andrisano
In our ongoing study focused on Corydalis cava (Fumariaceae), used in folk medicine in the treatment of memory dysfunctions, we have investigated fifteen previously isolated alkaloids for their potential multifunctional activity on Alzheimer's disease (AD) targets. Determination of ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibition was carried out using a BACE1-Immobilized Enzyme Reactor (IMER) by validating the assay with a multi-well plate format Fluorescence Resonance Energy Transfer (FRET) assay. Seven alkaloids out of fifteen were found to be active, with (-)-corycavamine (3) and (+)-corynoline (5) demonstrating the highest BACE1 inhibition activity, in the micromolar range, in a concentration dependent manner. BACE1-IMER was found to be a valid device for the fast screening of inhibitors and the determination of their potency. In a permeation assay (PAMPA) for the prediction of blood-brain barrier (BBB) penetration, the most active compounds, (-)-corycavamine (3) and (+)-corynoline (5), were found to be able to cross the BBB. Not all compounds showed activity against glycogen synthase kinase-3β (GSK-3β) and casein kinase-1δ (CK-1δ). On the basis of the reported results, we found that some C. cava alkaloids have multifunctional activity against AD targets (prolyl oligopeptidase, cholinesterases and BACE1). Moreover, we tried to elucidate the treatment effectivity (rational use) of its extract in memory dysfunction in folk medicine.

13 January 2016 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
Jakub ChlebekJakub Chlebek
Jakub Chlebek
ZNZdeněk Novák
Zdeněk Novák
DKDominika Kassemová
Dominika Kassemová
MŠMarcela Šafratová
Marcela Šafratová
JKJan Kostelník
Jan Kostelník
Lucie CahlikovaLucie Cahlikova
Lucie Cahlikova

3 November 2015 in Journal of Natural Products
Verified
Journal Article
Closed access
LZLucie Zemanova
Lucie Zemanova
JHJakub Hofman
Jakub Hofman
ENEva Novotna
Eva Novotna
KMKamil Musilek
Kamil Musilek
TLTereza Lundova
Tereza Lundova
VWVladimír Wsól
Vladimír Wsól